{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:30:11Z","timestamp":1761823811227},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T00:00:00Z","timestamp":1464220800000},"content-version":"vor","delay-in-days":146,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Case Reports"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/j.ebcr.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T01:02:36Z","timestamp":1464829356000},"page":"28-29","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Add-on perampanel in Lance\u2013Adams syndrome"],"prefix":"10.1016","volume":"6","author":[{"given":"Bernhard J.","family":"Steinhoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke M.","family":"Staack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhold","family":"Kornmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebcr.2016.05.001_bb0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2014.891580","article-title":"The discovery and development of perampanel for the treatment of epilepsy","volume":"9","author":"Hanada","year":"2014","journal-title":"Expert Opin Drug Discovery"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ane.12100","article-title":"Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist","volume":"197","author":"Rogawski","year":"2013","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","article-title":"Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304","volume":"79","author":"French","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2012.03638.x","article-title":"Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305","volume":"54","author":"French","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0025","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0030","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/epi.12212","article-title":"Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies","volume":"54","author":"Steinhoff","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0035","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic\u2013clonic seizures in idiopathic generalized epilepsy. A randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ebcr.2014.09.003","article-title":"Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel","volume":"2","author":"Dirani","year":"2014","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ebcr.2013.07.003","article-title":"Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease)","volume":"1","author":"Schorlemmer","year":"2013","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ebcr.2015.06.007","article-title":"Use of perampanel in one case of super-refractory hypoxic myoclonic status: case report","volume":"4","author":"Santamarina","year":"2015","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2298\/VSP1405515B","article-title":"Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy. A case report","volume":"71","author":"Bozic","year":"2014","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/WNF.0b013e3181e1613f","article-title":"Posthypoxic myoclonus (Lance\u2013Adams syndrome) treated with lacosamide","volume":"33","author":"Galldiks","year":"2010","journal-title":"Clin Neurophyarmacol"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0065","first-page":"57","article-title":"Levetiracetam for the mangement of Lance\u2013Adams syndrome","volume":"8","author":"Ilik","year":"2014","journal-title":"Iran J Child Neurol"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneur.1979.00500370074019","article-title":"Post-anoxic action myoclonus (Lance\u2013Adams syndrome) responding to valproate","volume":"36","author":"Rollinson","year":"1979","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0075","first-page":"618","article-title":"Use of clonazepam and valproate in patients with Lance\u2013Adams syndrome","volume":"86","author":"Wicklein","year":"1993","journal-title":"J R Soc Med"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0080","first-page":"357","article-title":"Effects of piracetam therapy in a case of Lance\u2013Adams syndrome","volume":"41","author":"Hoshino","year":"2009","journal-title":"No To Hattatsu"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0085","first-page":"654","article-title":"Case of intention myoclonus (Lance\u2013Adams syndrome) and a dramatic effect of l-5-hydroxytryptophan","volume":"16","author":"Satoyoshi","year":"1976","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00313141","article-title":"Post-anoxic mayoclonus (Lance\u2013Adams syndrome) treated with levodopa and GABAergic drugs","volume":"223","author":"Coletti","year":"1980","journal-title":"J Neurol"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mds.870070122","article-title":"Effect of alcohol on action myoclonus in Lance\u2013Adams syndrome and progressive myoclonus epilepsy","volume":"7","author":"Genton","year":"1992","journal-title":"Mov Disord"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0310057X0903700214","article-title":"A patient with intractable posthypoxic myoclonus (Lance\u2013Adams syndrome) treated with sodium oxybate","volume":"37","author":"Arpesella","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.pmrj.2010.12.023","article-title":"The use of intrathecal baclofen therapy for myoclonus in a patient with Lance\u2013Adams syndrome","volume":"3","author":"Birthi","year":"2011","journal-title":"PM R"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0110","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00415-015-7748-x","article-title":"Alleviation of myoclonus after bilateral pallidal deep brain stimulation for Lance\u2013Adams syndrome","volume":"262","author":"Asahi","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0115","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.0b013e31821482f4","article-title":"Gpi pallidal stimulation for Lance\u2013Adams syndrome","volume":"76","author":"Yamada","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/ane.12529","article-title":"Perampanel for focal epilepsy: insights from early clinical experience","volume":"133","author":"Trinka","year":"2016","journal-title":"Acta Naurol Scand"},{"key":"10.1016\/j.ebcr.2016.05.001_bb0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12865","article-title":"The clinical pharmacology profile of the new antiepileptic drug perampanel: a novel noncompetitive AMPA receptor antagonist","volume":"56","author":"Patsalos","year":"2015","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323216300305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323216300305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:56:43Z","timestamp":1567990603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213323216300305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":25,"alternative-id":["S2213323216300305"],"URL":"https:\/\/doi.org\/10.1016\/j.ebcr.2016.05.001","relation":{},"ISSN":["2213-3232"],"issn-type":[{"value":"2213-3232","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Add-on perampanel in Lance\u2013Adams syndrome","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebcr.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}